Mai-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
3,267
Total Value
11419085126
Accession Number
0001040197-25-000002
Form Type
13F-HR
Manager Name
Mai-Capital-Management
Data Enrichment
70% identified
2,291 identified976 unidentified

Holdings

3,267 positions • $11.4B total value
Manager:
Search and click to pin securities to the top
Page 156 of 164
Cue Biopharma, Inc.
Shares:350
Value:$319
% of Portfolio:0.0% ($319/$11.4B)
45826T509
Shares:256
Value:$318
% of Portfolio:0.0% ($318/$11.4B)
53630L209
Shares:125
Value:$314
% of Portfolio:0.0% ($314/$11.4B)
Brookfield Wealth Solutions Ltd.
Shares:6
Value:$314
% of Portfolio:0.0% ($314/$11.4B)
FUELCELL ENERGY INC
Shares:68
Value:$313
% of Portfolio:0.0% ($313/$11.4B)
Cryoport, Inc.
Shares:51
Value:$311
% of Portfolio:0.0% ($311/$11.4B)
Clene Inc.
Shares:100
Value:$308
% of Portfolio:0.0% ($308/$11.4B)
G3R25D118
Shares:1.2K
Value:$307
% of Portfolio:0.0% ($307/$11.4B)
HIGHLAND OPPORTUNITIES & INCOME FUND
Shares:59
Value:$307
% of Portfolio:0.0% ($307/$11.4B)
464286285
Shares:8
Value:$306
% of Portfolio:0.0% ($306/$11.4B)
Assertio Holdings, Inc.
Shares:445
Value:$301
% of Portfolio:0.0% ($301/$11.4B)
Capri Holdings Ltd
Shares:15
Value:$296
% of Portfolio:0.0% ($296/$11.4B)
SAB Biotherapeutics, Inc.
Shares:217
Value:$296
% of Portfolio:0.0% ($296/$11.4B)
G9892K209
Shares:229
Value:$291
% of Portfolio:0.0% ($291/$11.4B)
ONCOLYTICS BIOTECH INC
Shares:526
Value:$290
% of Portfolio:0.0% ($290/$11.4B)
Atea Pharmaceuticals, Inc.
Shares:95
Value:$285
% of Portfolio:0.0% ($285/$11.4B)
74915M100
Shares:1.4K
Value:$272
% of Portfolio:0.0% ($272/$11.4B)
McEwen Mining Inc.
Shares:36
Value:$272
% of Portfolio:0.0% ($272/$11.4B)
46138T104
Shares:4
Value:$272
% of Portfolio:0.0% ($272/$11.4B)
025072216
Shares:4
Value:$270
% of Portfolio:0.0% ($270/$11.4B)